Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,221.60
-37.20 (-1.65%)
Oct 21, 2026, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 168.84 billion as of October 21, 2026. Its market cap has increased by 10.44% in one year.
Market Cap
168.84B
Enterprise Value
160.01B
Revenue
22.87B
Global Rank
n/a
Country Rank
n/a
PE Ratio
25.38
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 168.84B, an increase of 3,015,388.11%. That is a compound annual growth rate of 51.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 168.84B | 20.64% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 335.09B |
| Wockhardt | 309.76B |
| Piramal Pharma | 258.46B |
| Cohance Lifesciences | 175.11B |
| Alivus Life Sciences | 155.71B |
| Eris Lifesciences | 155.44B |
| Alembic Pharmaceuticals | 155.35B |
| NATCO Pharma | 143.83B |